WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Feb 27, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-25

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-25	Common Stock	M	4729.0000	$42.4400	Acquired	13966.1040	Direct
2013-02-25	Common Stock	M	4281.0000	$40.8500	Acquired	18247.1040	Direct
2013-02-25	Common Stock	F	6370.0000	$60.1000	Disposed	11877.1040	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-25	Stock Option (Right to Buy)	$42.4400	M	4729.0000	Disposed	2022-02-21	Common Stock (4729.0000)	Direct
2013-02-25	Stock Option (Right to Buy)	$40.8500	M	4281.0000	Disposed	2021-02-21	Common Stock (4281.0000)	Direct